CARDIOTOXIC Study: Relationship Between Cancer Therapy and CVD
Certain classes of anticancer drugs are cardiotoxic, especially the anthracycline group of chemotherapeutic agents. In most cases, the cardiotoxic... Read more
Cardiovascular Outcomes in Women: Biology or Bias?
Women have steeper increases in blood pressure than men throughout their life, and cardiovascular disease presents itself much differently in... Read more
Impact of Cardiac Radiation on Risk of Coronary Artery Disease
Over the years, there has been significant progress in the treatment of children with cancer. This has resulted in an increase in the number... Read more
ODYSSEY Outcomes Trial: Does Reduction of Lipoprotein Reduce Cardiovascular Risk?
Lipoprotein is believed to possess pro-atherogenic, pro-thrombotic, pro-inflammatory, and pro-oxidative properties. High levels of lipoprotein... Read more
Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions and leads... Read more
Chelsea Beecher serves as the Director of Development for the American Heart & Stroke Association in New York City. She led the launch of STEM Goes Red in New York City and received the Innovator of the Year Award in 2018 for this initiative. STEM Goes Red aims to empower young women to pursue science, technology, engineering, and math (STEM)... Read more
Robots were first used in cardiovascular medicine in the late 1990s as a part of the digital revolution . Since then, robotics have been applied to endovascular surgery, minimally invasive cardiac surgery, and interventional cardiology, to name a few fields. Robots give medical professionals the ability to diagnose, treat, and intervene more... Read more
Radiomics and Imaging: The Need for Standardisation
Summary: Radiomics holds great promise for personalised... Read more
Power to the People: How the Economics of Information is Empowering Patients
During the 2000s, England’s National Health Service spent an extra $1.5... Read more
The Task Force® Monitor is the all‐in‐one workstation for continuous noninvasive hemodynamic and autonomic assessment. It is the state‐of‐the‐art diagnostic tool to study syncope and autoregulation of blood pressure and has further established as an...
The CNAP® Monitor represents the next generation of noninvasive patient monitoring by merging the advantages of noninvasive, risk‐free methods with the benefits of continuity in the same accuracy as invasive standards. The advanced parameter set enables...